Clinical trial

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

NCT01836679

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE2

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2016-02-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small-cell Lung Cancerunresolved

Interventions

ChidamideDRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

CarboplatinDRUG · verified · RxNorm: carboplatin

PlaceboDRUG

Sponsors & collaborators

Chipscreen Biosciences, Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China2 ShanghaiShanghai Municipality, China1 NanjingJiangsu, China1 ChengduSichuan, China1 TianjinTianjin Municipality, China1 ShenyangLiaoning, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01836679 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.